Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet C Lindsey

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
Cancer Cell|December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseRebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncotarget|January 18, 2018
Development of a targeted sequencing approach to identify prognostic, predictive and diagnostic markers in paediatric solid tumoursElisa Izquierdo, Lina Yuan, Sally George, et al.
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
Cancer Cell|December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseRebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2013
Subgroup-specific prognostic implications of TP53 mutation in medulloblastomaNataliya Zhukova, Vijay Ramaswamy, Marc Remke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Nature|January 14, 2016
Divergent clonal selection dominates medulloblastoma at recurrenceA Sorana Morrissy, Livia Garzia, David J H Shih, et al.
Pageof 3